Typical features of calciphylaxis in a patient with end-stage renal failure, diabetes mellitus and oral anticoagulation

Dermatology

Volumn 200, Issue 4, 2000, Pages 356-359

  Streit, Markus ^a,c   Paredes, B E ^a   Ruegger S ^b   Brand, C U ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b Spitalzentrum ^*  (Switzerland)

^c UNIVERSITY OF BERN   (Switzerland)

Author keywords

Anticoagulation; Calciphylaxis; Diabetes mellitus; End stage renal failure

Indexed keywords

ALBUMIN; ALKALINE PHOSPHATASE; ALUMINUM HYDROXIDE; ANTIBIOTIC AGENT; ANTICOAGULANT AGENT; ANTIINFLAMMATORY AGENT; C REACTIVE PROTEIN; CALCIUM CARBONATE; CALCIUM PHOSPHATE; CREATININE; HEMOGLOBIN; INSULIN; OPIATE; PARATHYROID HORMONE;

AGED; ANTICOAGULATION; CALCINOSIS; CASE REPORT; CLINICAL FEATURE; CONFERENCE PAPER; DIABETES MELLITUS; FEMALE; HUMAN; KIDNEY FAILURE; PAIN; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR;

EID: 0033932106     PISSN: 10188665     EISSN: None     Source Type: Journal    
DOI: 10.1159/000018410     Document Type: Conference Paper

References (14)